Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
52,870,098
-
Total 13F shares
-
25,194,781
-
Share change
-
-8,382
-
Total reported value
-
$579,384,885
-
Price per share
-
$22.99
-
Number of holders
-
131
-
Value change
-
-$192,256
-
Number of buys
-
2
-
Number of sells
-
3
Institutional Holders of Emergent BioSolutions Inc. - COMMON STOCK (EBS) as of Q4 2013
As of 31 Dec 2013,
Emergent BioSolutions Inc. - COMMON STOCK (EBS) was held by
131 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,194,781 shares.
The largest 10 holders included
Bank of New York Mellon Corp, VANGUARD GROUP INC, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, Consonance Capital Management LP, Broadfin Capital, LLC, BlackRock Institutional Trust Company, N.A., SAC Capital Advisors LP, LOOMIS SAYLES & CO L P, and State Street Corp.
This page lists
131
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.